1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Ghana Pharmaceuticals and Healthcare Report Q2 2016

Ghana Pharmaceuticals and Healthcare Report Q2 2016

  • March 2016
  • -
  • Business Monitor International
  • -
  • 80 pages

Includes 3 FREE quarterly updates

BMI View: The Ghanaian government is actively making progress towards fulfilling its ambition of beingthe Economic Communities of West African States (ECOWAS) hub for pharmaceutical and healthcareinvestment. Domestic drugmakers are in a favourable position to take advantage of the growing regionaldemand for medicines, while the government, in association with foreign aid agencies, is continuing toupgrade local export capacities.

The larger domestic manufacturers will look to gain WHO certificationand fulfilment of export potential needs for Good Manufacturing Practice certification. This would allowGhana to reduce its unsustainable reliance on imported pharmaceuticals, however cheaper generic importsthreaten the competitiveness of Ghanaian domestic drug manufacturers on a domestic and regional scale.Headline Expenditure ProjectionsPharmaceuticals: GHS1.18bn (USD311mn) in 2015 to GHS1.37bn (USD340mn) in 2016; +16.3% in localcurrency terms and +9.5% in US dollar terms. Forecast unchanged from Q116.Healthcare: GHS6.60bn (USD1.74bn) in 2015 to GHS7.47bn (USD1.86bn) in 2016; +13.3% in localcurrency terms and +6.6% in US dollar terms. Forecast in line with Q415.

Table Of Contents

Ghana Pharmaceuticals and Healthcare Report Q2 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Ghana 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Ghana 2012-2020) 14
Healthcare Market Forecast 15
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 17
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 17
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Ghana 2012-2020) 18
Prescription Drug Market Forecast 19
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 20
Patented Drug Market Forecast 21
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 23
Generic Drug Market Forecast 24
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 25
OTC Market Forecast 26
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Ghana 2012-2020) 27
Pharmaceutical Trade Forecast 28
Table: Pharmaceutical Trade Data And Forecasts (Ghana 2014-2020) 31
Table: Pharmaceutical Trade Data And Forecasts Local Currency (Ghana 2014-2020) 31
Industry Risk/Reward Index 32
Middle East and Africa Risk/Reward Index - Q2 2016 32
Ghana Risk/Reward Index 39
Rewards 39
Risks 40
Regulatory Review 42
Intellectual Property Issues 43
Pricing And Reimbursement Regime 44
Market Overview 47
Healthcare Sector 48
Table: Healthcare Resources (Ghana 2010-2015) 51
Table: Healthcare Personnel (Ghana 2010-2015) 51
Table: Healthcare Activity (Ghana 2010-2015) 52
Research and Development 52
Clinical Trials 52
Epidemiology 54
Competitive Landscape 57
Research-Based Industry 57
Table: Multinational Market Activity 59
Generic Drugmakers 60
Pharmaceutical Distribution 60
Pharmaceutical Retail Sector 61
Company Profile 62
Ayrton Drug Manufacturing Company (Adcock Ingram) 62
Danadams 65
Demographic Forecast 69
Table: Population Headline Indicators (Ghana 1990-2025) 70
Table: Key Population Ratios (Ghana 1990-2025) 70
Table: Urban/Rural Population and Life Expectancy (Ghana 1990-2025) 71
Table: Population By Age Group (Ghana 1990-2025) 71
Table: Population By Age Group % (Ghana 1990-2025) 72
Glossary 74
Methodology 76
Pharmaceutical Expenditure Forecast Model 76
Healthcare Expenditure Forecast Model 76
Notes On Methodology 77
Risk/Reward Index Methodology 78
Index Overview 79
Table: Pharmaceutical Risk/Reward Index Indicators 79
Indicator Weightings 80

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.